Literature DB >> 14676259

Clinical implications of the new definition of myocardial infarction.

John K French1, Harvey D White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14676259      PMCID： PMC1768007          DOI： 10.1136/heart.90.1.99

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

Review 1.  Recognition of the importance of embolization in atherosclerotic vascular disease.

Authors:  E J Topol; J S Yadav
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

2.  Frequency and long-term impact of myonecrosis after coronary stenting.

Authors:  S J Brener; S G Ellis; J Schneider; E J Topol
Journal:  Eur Heart J       Date:  2002-06       Impact factor: 29.983

3.  ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).

Authors:  E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; R J Gibbons; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

Review 4.  Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes.

Authors:  L Kristin Newby; Britta U Goldmann; E Magnus Ohman
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

5.  Myocardial infarction as a complication of coronary bypass surgery.

Authors:  D L Brewer; R H Bilbro; A G Bartel
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

6.  Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.

Authors:  M P Hudson; C B Granger; E J Topol; K S Pieper; P W Armstrong; G I Barbash; A D Guerci; A Vahanian; R M Califf; E M Ohman
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

7.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.

Authors:  A E Abdelmeguid; E J Topol; P L Whitlow; S K Sapp; S G Ellis
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery.

Authors:  B R Chaitman; E L Alderman; L T Sheffield; T Tong; L Fisher; M B Mock; R D Weins; G C Kaiser; D Roitman; R Berger; B Gersh; H Schaff; M G Bourassa; T Killip
Journal:  Circulation       Date:  1983-02       Impact factor: 29.690

9.  Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Authors:  Ronnier J Aviles; Arman T Askari; Bertil Lindahl; Lars Wallentin; Gang Jia; E Magnus Ohman; Kenneth W Mahaffey; L Kristin Newby; Robert M Califf; Maarten L Simoons; Eric J Topol; Peter Berger; Michael S Lauer
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

10.  The prognostic value of serum troponin T in unstable angina.

Authors:  C W Hamm; J Ravkilde; W Gerhardt; P Jørgensen; E Peheim; L Ljungdahl; B Goldmann; H A Katus
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245
View more
  30 in total

1.  End points in clinical trials: are they moving the goalposts?

Authors:  D Y Leung; J K French
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 2.  Troponin I in the intensive care unit setting: from the heart to the heart.

Authors:  Chiara Lazzeri; Manuela Bonizzoli; Giovanni Cianchi; Gian Franco Gensini; Adriano Peris
Journal:  Intern Emerg Med       Date:  2008-03-07       Impact factor: 3.397

3.  Efficacy of Xuebijing Injection () on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial.

Authors:  Wei Gao; Na Li; Xiao-Guang Cui
Journal:  Chin J Integr Med       Date:  2018-07-31       Impact factor: 1.978

Review 4.  Implications of the new definition of myocardial infarction.

Authors:  C-K Wong; H D White
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

5.  Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.

Authors:  Keun-Ho Park; Youngkeun Ahn; Myung Ho Jeong; Shung Chull Chae; Seung Ho Hur; Young Jo Kim; In Whan Seong; Jei Keon Chae; Taek Jong Hong; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Yang Soo Jang
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

6.  Heparin responsiveness during off-pump coronary artery bypass graft surgery: predictors and clinical implications.

Authors:  Duk-hee Chun; Seong-wan Baik; So Yeon Kim; Jae Kwang Shim; Jong Chan Kim; Young Lan Kwak
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

7.  Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).

Authors:  John K French; Shannon Harkness; Lynn Sleeper; S Chiu Wong; Jacques Col; Vladimir Dzavik; Harvey D White; Judith S Hochman
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

8.  The clinical significance of cardiac troponins in medical practice.

Authors:  Mohammed A Al-Otaiby; Hussein S Al-Amri; Abdulrahman M Al-Moghairi
Journal:  J Saudi Heart Assoc       Date:  2010-10-20

Review 9.  An historical approach to the diagnostic biomarkers of acute coronary syndrome.

Authors:  Elisa Danese; Martina Montagnana
Journal:  Ann Transl Med       Date:  2016-05

10.  Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis.

Authors:  Sebastien Jacquet; Xiaoke Yin; Pierre Sicard; James Clark; Gajen S Kanaganayagam; Manuel Mayr; Michael S Marber
Journal:  Mol Cell Proteomics       Date:  2009-08-31       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.